It will be important to determine whether more severe impairment of calcium channel function is present in dystroglycanopathies, a group of muscular dystrophies where the function of dystroglycan is the primary molecular defect [81]. The gene discussed is DAG1; the disease is neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.